NasdaqGS:BIIBBiotechs
Assessing Biogen (BIIB) Valuation After Recent Share Price Momentum And Earnings Expectations
Biogen stock reaction and recent performance snapshot
Biogen (BIIB) has been in focus for investors after recent trading left the stock at a last close of $192.95. This has prompted fresh attention on how its current valuation lines up with underlying fundamentals.
Over the past month the stock gained 8.8%, while the past 3 months show a decline of 1.4%. Year to date, Biogen is up 8.5%, and the 1 year total return stands at 49.1%.
See our latest analysis for Biogen.
The recent 1 month share...